249 related articles for article (PubMed ID: 22275377)
1. Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).
Canaff L; Vanbellinghen JF; Kaji H; Goltzman D; Hendy GN
J Biol Chem; 2012 Mar; 287(11):8584-97. PubMed ID: 22275377
[TBL] [Abstract][Full Text] [Related]
2. Menin and TGF-beta superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast.
Hendy GN; Kaji H; Sowa H; Lebrun JJ; Canaff L
Horm Metab Res; 2005 Jun; 37(6):375-9. PubMed ID: 16001330
[TBL] [Abstract][Full Text] [Related]
3. Correlation of mutant menin stability with clinical expression of multiple endocrine neoplasia type 1 and its incomplete forms.
Shimazu S; Nagamura Y; Yaguchi H; Ohkura N; Tsukada T
Cancer Sci; 2011 Nov; 102(11):2097-102. PubMed ID: 21819486
[TBL] [Abstract][Full Text] [Related]
4. Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.
Hussein N; Lu J; Casse H; Fontanière S; Morera AM; Guittot SM; Calender A; Di Clemente N; Zhang CX
Endocr Relat Cancer; 2008 Mar; 15(1):217-27. PubMed ID: 18310289
[TBL] [Abstract][Full Text] [Related]
5. Menin expression is regulated by transforming growth factor beta signaling in leukemia cells.
Zhang H; Liu ZG; Hua XX
Chin Med J (Engl); 2011 May; 124(10):1556-62. PubMed ID: 21740816
[TBL] [Abstract][Full Text] [Related]
6. Menin inactivation leads to loss of transforming growth factor beta inhibition of parathyroid cell proliferation and parathyroid hormone secretion.
Sowa H; Kaji H; Kitazawa R; Kitazawa S; Tsukamoto T; Yano S; Tsukada T; Canaff L; Hendy GN; Sugimoto T; Chihara K
Cancer Res; 2004 Mar; 64(6):2222-8. PubMed ID: 15026366
[TBL] [Abstract][Full Text] [Related]
7. Menin and bone metabolism.
Kaji H
J Bone Miner Metab; 2012 Jul; 30(4):381-7. PubMed ID: 22543820
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
[TBL] [Abstract][Full Text] [Related]
9. Expression and functional analysis of menin in a multiple endocrine neoplasia type 1 (MEN1) patient with somatic loss of heterozygosity in chromosome 11q13 and unidentified germline mutation of the MEN1 gene.
Naito J; Kaji H; Sowa H; Kitazawa R; Kitazawa S; Tsukada T; Hendy GN; Sugimoto T; Chihara K
Endocrine; 2006 Jun; 29(3):485-90. PubMed ID: 16943588
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics analyses of MEN1 missense mutations identify disruption of menin-MLL and menin-JunD interactions as critical requirements for molecular pathogenicity.
Dreijerink KMA; Ozyerli-Goknar E; Koidl S; van der Lelij EJ; van den Heuvel P; Kooijman JJ; Biniossek ML; Rodenburg KW; Nizamuddin S; Timmers HTM
Epigenetics Chromatin; 2022 Aug; 15(1):29. PubMed ID: 35941657
[TBL] [Abstract][Full Text] [Related]
11. New splicing mutation of MEN1 gene affecting the translocation of menin to the nucleus.
Tala HP; Carvajal CA; González AA; Garrido JL; Tobar J; Solar A; Campino C; Arteaga E; Fardella CE
J Endocrinol Invest; 2006 Nov; 29(10):888-93. PubMed ID: 17185897
[TBL] [Abstract][Full Text] [Related]
12. Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients.
Luzi E; Marini F; Tognarini I; Carbonell Sala S; Galli G; Falchetti A; Brandi ML
Cancer Gene Ther; 2010 Nov; 17(11):814-25. PubMed ID: 20706287
[TBL] [Abstract][Full Text] [Related]
13. Functional studies of the MEN1 gene.
Chandrasekharappa SC; Teh BT
J Intern Med; 2003 Jun; 253(6):606-15. PubMed ID: 12755956
[TBL] [Abstract][Full Text] [Related]
14. The role of menin in parathyroid tumorigenesis.
Davenport C; Agha A
Adv Exp Med Biol; 2009; 668():79-86. PubMed ID: 20175455
[TBL] [Abstract][Full Text] [Related]
15. Osteoblast menin regulates bone mass in vivo.
Kanazawa I; Canaff L; Abi Rafeh J; Angrula A; Li J; Riddle RC; Boraschi-Diaz I; Komarova SV; Clemens TL; Murshed M; Hendy GN
J Biol Chem; 2015 Feb; 290(7):3910-24. PubMed ID: 25538250
[TBL] [Abstract][Full Text] [Related]
16. Internally shortened menin protein as a consequence of alternative RNA splicing due to a germline deletion in the multiple endocrine neoplasia type 1 gene.
Roijers JF; Apel T; Neumann HP; Arnim UV; Lips CJ; Hoppener JW
Int J Mol Med; 2000 Jun; 5(6):611-4. PubMed ID: 10812010
[TBL] [Abstract][Full Text] [Related]
17. Menin molecular interactions: insights into normal functions and tumorigenesis.
Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ
Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia type 1 associated with a new germline Men1 mutation in a family with atypical tumor phenotype.
Perakakis N; Flohr F; Kayser G; Thomusch O; Parsons L; Billmann F; von Dobschuetz E; Rondot S; Seufert J; Laubner K
Hormones (Athens); 2016; 15(1):113-7. PubMed ID: 26732163
[TBL] [Abstract][Full Text] [Related]
19. Menin is required for optimal processing of the microRNA let-7a.
Gurung B; Muhammad AB; Hua X
J Biol Chem; 2014 Apr; 289(14):9902-8. PubMed ID: 24563463
[TBL] [Abstract][Full Text] [Related]
20. Multiple endocrine neoplasia type 1.
Agarwal SK
Front Horm Res; 2013; 41():1-15. PubMed ID: 23652667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
